Overview

There has never been a greater need for long-term investments to tackle the world's most difficult problems, such as climate change, human health, and decaying infrastructure. And it is increasingly unlikely that the public sector will be willing or able to fill this gap. If these critical needs are to be met, the major pools of long-term, patient capital-including pensions, sovereign wealth funds, university endowments, and wealthy individuals and families-will have to play a large role. In this accessible and authoritative account of long-term capital investment, two leading experts on the subject, Victoria Ivashina and Josh Lerner, highlight the significant hurdles facing long-term investors and propose concrete ways to overcome these difficulties. 'Few scholarly, well-researched books have been written on long-term private investing. Victoria Ivashina and Josh Lerner have undertaken a real public service in writing what will undoubtedly become the definitive book on the subject. My only regret in reading this book is that I did not write it.' - David Rubenstein, Co-Founder and Co-Executive Chairman, The Carlyle Group 'The trees that are slowest to grow bear the best fruit,' Molire says. And that is why this lucid and refreshing account of how to overcome the barriers to long-term investment deserves the attention of pension funds, insurers, sovereign wealth funds, and endowments. After all, the potential fruits are not just quality returns, but significant benefits to society.' - Dominique Senequier, President, Ardian

Full Product Details

9780691217086

Table of Contents

Reviews

This book provides a thorough and thoughtful analysis of the role that patient, long-term capital plays in the economy. Ivashina and Lerner do a wonderful job of combining clear and intuitive explanations with entertaining anecdotes that keep the reader's attention and make it easier to understand the underlying ideas. At every point their in-depth knowledge shines through and makes for a very enjoyable read. --Antoinette Schoar, MIT Sloan School of Management Patient Capital is a compelling and thought-provoking book about an important but poorly understood aspect of finance--the role of long-term investors in our capital markets. It will appeal to finance scholars; those who work for pension funds, endowments, insurance companies, sovereign wealth funds, and the venture capital and private equity industries; and entrepreneurs who rely on them for financing. --Jeffrey R. Brown, Dean of the University of Illinois's Gies College of Business and Investment Committee Chair for TIAA You may not think your life depends on long-term investors, but it does--the health of your company's pension plan, your state or country's social security fund, indeed the very comfort of your retirement, depends on the success of long-term investing. In this very readable book, Ivashina and Lerner, two of the foremost experts on the subject, tell you what is going wrong, and how to set it right. It is a must-read for every anxious investor and every concerned taxpayer.--Raghuram Rajan, University of Chicago The antidote for short-term horizons in public markets is long-term investment in private markets. In Patient Capital, Ivashina and Lerner survey the private equity world, employing an engaging combination of captivating anecdotes and solid academic research. A must-read for all who care about the future of capitalism.--David F. Swensen, Chief Investment Officer, Yale University Few scholarly, well-researched books have been written on long-term private investing. Victoria Ivashina and Josh Lerner have undertaken a real public service in writing what will undoubtedly become the definitive book on the subject. My only regret in reading this book is that I did not write it.--David Rubenstein, Co-Founder and Co-Executive Chairman, The Carlyle Group 'The trees that are slowest to grow bear the best fruit, ' Moliere says. And that is why this lucid and refreshing account of how to overcome the barriers to long-term investment deserves the attention of pension funds, insurers, sovereign wealth funds, and endowments. After all, the potential fruits are not just quality returns, but significant benefits to society.--Dominique Senequier, President, Ardian

"'The trees that are slowest to grow bear the best fruit, ' Molière says. And that is why this lucid and refreshing account of how to overcome the barriers to long-term investment deserves the attention of pension funds, insurers, sovereign wealth funds, and endowments. After all, the potential fruits are not just quality returns, but significant benefits to society.--Dominique Senequier, President, Ardian Few scholarly, well-researched books have been written on long-term private investing. Victoria Ivashina and Josh Lerner have undertaken a real public service in writing what will undoubtedly become the definitive book on the subject. My only regret in reading this book is that I did not write it.--David Rubenstein, Co-Founder and Co-Executive Chairman, The Carlyle Group The antidote for short-term horizons in public markets is long-term investment in private markets. In Patient Capital, Ivashina and Lerner survey the private equity world, employing an engaging combination of captivating anecdotes and solid academic research. A must-read for all who care about the future of capitalism.--David F. Swensen, Chief Investment Officer, Yale University You may not think your life depends on long-term investors, but it does--the health of your company's pension plan, your state or country's social security fund, indeed the very comfort of your retirement, depends on the success of long-term investing. In this very readable book, Ivashina and Lerner, two of the foremost experts on the subject, tell you what is going wrong, and how to set it right. It is a must-read for every anxious investor and every concerned taxpayer.--Raghuram Rajan, University of Chicago ""Patient Capital is a compelling and thought-provoking book about an important but poorly understood aspect of finance--the role of long‐term investors in our capital markets. It will appeal to finance scholars; those who work for pension funds, endowments, insurance companies, sovereign wealth funds, and the venture capital and private equity industries; and entrepreneurs who rely on them for financing.""--Jeffrey R. Brown, Dean of the University of Illinois's Gies College of Business and Investment Committee Chair for TIAA ""This book provides a thorough and thoughtful analysis of the role that patient, long-term capital plays in the economy. Ivashina and Lerner do a wonderful job of combining clear and intuitive explanations with entertaining anecdotes that keep the reader's attention and make it easier to understand the underlying ideas. At every point their in-depth knowledge shines through and makes for a very enjoyable read.""--Antoinette Schoar, MIT Sloan School of Management"

'The trees that are slowest to grow bear the best fruit, ' Molière says. And that is why this lucid and refreshing account of how to overcome the barriers to long-term investment deserves the attention of pension funds, insurers, sovereign wealth funds, and endowments. After all, the potential fruits are not just quality returns, but significant benefits to society.--Dominique Senequier, President, Ardian Few scholarly, well-researched books have been written on long-term private investing. Victoria Ivashina and Josh Lerner have undertaken a real public service in writing what will undoubtedly become the definitive book on the subject. My only regret in reading this book is that I did not write it.--David Rubenstein, Co-Founder and Co-Executive Chairman, The Carlyle Group The antidote for short-term horizons in public markets is long-term investment in private markets. In Patient Capital, Ivashina and Lerner survey the private equity world, employing an engaging combination of captivating anecdotes and solid academic research. A must-read for all who care about the future of capitalism.--David F. Swensen, Chief Investment Officer, Yale University You may not think your life depends on long-term investors, but it does--the health of your company's pension plan, your state or country's social security fund, indeed the very comfort of your retirement, depends on the success of long-term investing. In this very readable book, Ivashina and Lerner, two of the foremost experts on the subject, tell you what is going wrong, and how to set it right. It is a must-read for every anxious investor and every concerned taxpayer.--Raghuram Rajan, University of Chicago ""Patient Capital is a compelling and thought-provoking book about an important but poorly understood aspect of finance--the role of long‐term investors in our capital markets. It will appeal to finance scholars; those who work for pension funds, endowments, insurance companies, sovereign wealth funds, and the venture capital and private equity industries; and entrepreneurs who rely on them for financing.""--Jeffrey R. Brown, Dean of the University of Illinois's Gies College of Business and Investment Committee Chair for TIAA ""This book provides a thorough and thoughtful analysis of the role that patient, long-term capital plays in the economy. Ivashina and Lerner do a wonderful job of combining clear and intuitive explanations with entertaining anecdotes that keep the reader's attention and make it easier to understand the underlying ideas. At every point their in-depth knowledge shines through and makes for a very enjoyable read.""--Antoinette Schoar, MIT Sloan School of Management

Author Information

Victoria Ivashina is the Lovett-Learned Professor of Finance at Harvard Business School. Josh Lerner is the Jacob H. Schiff Professor of Investment Banking at Harvard Business School and the author of, among other books, Boulevard of Broken Dreams: Why Public Efforts to Boost Entrepreneurship and Venture Capital Have Failed-and What to Do about It (Princeton).

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available